MBOT

Microbot Medical Inc.

Price

$1.49

return (12m)

-62.88%

p/e

-6.07

p/bv

1.44

DIVIDEND YIELD

0.00%

MBOT price

Microbot Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MBOT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-13.16%

3 months

-26.85%

1 year

-62.88%

2 years

56.78%

5 years

-80.07%

10 years

-99.31%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals MBOT

Valuation

P/E

-6.07

Sector -4.26

Industry -4.26

P/BV

1.44

Sector 2.11

Industry 2.11

P/Revenue (PSR)

291.65

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

1.35

Sector 1.25

Industry 1.25

P/Net Current Assets

1.46

Sector -5.47

Industry -5.47

P/Working Capital

1.45

Sector -1.10

Industry -1.10

EPS

-0.24

Sector -1.94

Industry -1.94

BVPS

1.03

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

-100.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-23.71%

Sector -61.50%

Industry -61.50%

ROA

-22.27%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

18.55

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.94

Sector 0.43

Industry 0.43

Liabilities/Assets

0.06

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

7.62%

Sector -

Industry -

Fundamentals MBOT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MBOT Microbot Medical Inc.	$1.49	-63.51%	0.00%	-6.07	1.44	-23.71%	-100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MBOT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Microbot Medical

Microbot Medical Inc.

Average Investor10 user rating

4.0 (2 people)

United States

38 years

Founded: 1988

1992

Time since IPO - 34 years

9

Employees

Microbot Medical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $99.16 million, with shareholders equity totaling $68.93 million.

The company employs approximately 9 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Microbot Medical Inc. reported $340.00 Thousand in revenue, generating net income of $-16.34 million.

Key financial metrics include a P/E ratio of -6.07, a price-to-book (P/B) ratio of 1.44, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MBOT.

Market cap

$99.16 million

Net worth

$68.93 million

$68,930,000.00

Assets

$73.36 million

$73,360,000.00

Total Shares Outstanding

67.00 million

67,000,000

Average Daily Trading Volume

$754.97 Thousand

$754,969.66

Sector

Health Care

Industry

Biotechnology

MBOT

MBOT revenue and profits

Financial Results MBOT

DRAG THE FRAME TO SEE MORE DATA

MBOT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Microbot Medical (MBOT) today?

A cotação de Microbot Medical (MBOT) hoje está em US$ 1.49, com uma variação de -62.88% em relação ao último ano. A cotação de Microbot Medical (MBOT) iniciou o ano negociando na casa dos US$ 2.00 e hoje está em US$ 1.49. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Microbot Medical (MBOT) e dados de ações do Ibovespa e mercados internacionais.

Quando Microbot Medical (MBOT) paga dividendos?

Microbot Medical (MBOT) não distribuiu dividendos no último ano.

Is Microbot Medical (MBOT) a good investment?

Atualmente, Microbot Medical (MBOT) está cotada a US$ 1.49, com um P/L de -6.07, representando um desvio de -436% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -62.88 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -62.88%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Microbot Medical (MBOT) stock?

Investir em ações de Microbot Medical (MBOT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Microbot Medical (MBOT) yield today?

A rentabilidade de Microbot Medical (MBOT) foi de -13.16% no último mês, -62.88% no último ano e -80.07% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Microbot Medical (MBOT) hoje, o investimento total seria de US$ 148.50, com base na cotação atual de US$ 1.49.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 55.12
Em 5 anos: US$ 29.60
Em 10 anos: US$ 1.02

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MBOT

Microbot Medical Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MBOT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MBOT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Microbot Medical

Microbot Medical Inc.

United States

38 years

1992

9

PROFIT X PRICE MBOT

Financial Results MBOT

MBOT cash flow

Asset, Revenue and Profit Growth - MBOT

MBOT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions